- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alivus Life Sciences Limited — Updates, 06-11-2025: Press Release
06-11-2025 | 06:55 pm
06-11-2025 | 06:55 pm
Alivus Life Sciences delivered strong Q2FY26 results: Revenue grew 16% YoY to ₹588 Cr, EBITDA margins hit 33% (+480 bps). Non-GPL business surged 39.7%. H1FY26 saw strong free cash flow (₹147.7 Cr) and a debt-free balance sheet (₹652.6 Cr cash). Confident of H2 growth and 30% margins.
No comments yet. Be the first to comment!